Using the LINE@ Online Platform to Follow Up on Illegal Drug Use Among College and University Students

December 16, 2025 updated by: Li Yi Xuan, National Taiwan Normal University

Using Line@ Online Platform to Follow up on Counseling Intervention Effectiveness for Illegal Drug Use Among College and University Students

This study developed a LINE@ online platform for tracking college and university students involved in illegal drug use, with the aim of evaluating the effectiveness of the intervention.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Effectiveness indicators were collected using a structured questionnaire, including family functioning, severity of substance dependence, motivation for change, and emotional health management. In addition, a structured questionnaire was used to gather university students' user evaluations of the LINE@ online platform.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Taiwan
    • Heping E. Rd
      • Taipei, Heping E. Rd, Taiwan, 106
        • Recruiting
        • National Taiwan Normal University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • College students with a history of illegal drug use (confirmed by urine screening or other methods, such as self-reported use, curiosity-driven misuse, or accidental use)

Exclusion Criteria:

  • Younger than 18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: LINE@ Online Platform Intervention Group
LINE@ Online Platform Intervention
Device: LINE@ Online Platform Intervention
Using digital learning materials covering family functioning, substance dependence severity, motivation for change, and emotional health management.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Family Functioning
Time Frame: To be completed within 2 months from the start of participation
1.Assessment of family dynamics and functioning using using validated scales FAMILY APGAR (questionnaire). 2.The score ranges from 0 to 10, with higher scores indicating better family functioning.
To be completed within 2 months from the start of participation
Severity of Substance Dependence
Time Frame: To be completed within 2 months from the start of participation
1.Evaluation of the severity of substance dependence among participants using validated scales The Severity of Dependence Scale (questionnaire). 2.The score ranges from 0 to 15, with higher scores indicating a greater level of substance dependence in the participant.
To be completed within 2 months from the start of participation
Motivation for Change
Time Frame: To be completed within 2 months from the start of participation
1.Measurement of participants' motivation to change their substance use using validated scales University of Rhode Island Change Assessment (questionnaire). 2.The score ranges from 2 to 10, with higher scores indicating a greater severity of addictive behaviors and a higher level of motivation to change in the participant's clinical course.
To be completed within 2 months from the start of participation
Emotional Health Management
Time Frame: To be completed within 2 months from the start of participation
1.Assessment of emotional health management skills through using validated scales Brief Symptom Rating Scale (questionnaire). 2.The score ranges from 0 to 20, with higher scores indicating a greater level of emotional distress.
To be completed within 2 months from the start of participation
Drug Abuse Screening Test
Time Frame: To be completed within 2 months from the start of participation
1.Survey on illegal drug use in the past 1 month using validated scales Drug Abuse Screening Test (questionnaire). 2.The score ranges from 0 to 10, with higher scores indicating a higher risk level of illegal drug use.
To be completed within 2 months from the start of participation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
User Evaluation of the LINE@ Online Platform
Time Frame: To be completed within 2 months from the start of participation
1.Participants' evaluation of the usability and effectiveness of the LINE@ platform using validated scales System usability scale (questionnaire). 2.The score ranges from 0 to 100, with higher scores indicating a higher evaluation of the educational material by the participants.
To be completed within 2 months from the start of participation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Taiwan Normal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2026

Study Registration Dates

First Submitted

September 16, 2025

First Submitted That Met QC Criteria

December 16, 2025

First Posted (Actual)

December 31, 2025

Study Record Updates

Last Update Posted (Actual)

December 31, 2025

Last Update Submitted That Met QC Criteria

December 16, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 202506HM023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Illegal Drug Use

Clinical Trials on LINE@ Online Platform Intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe